Not surprisingly, Liu et al. concluded that high expression of ALDH1A1 transcripts may be an independent predictor of a favorable outcome in patients with triple-negative breast cancer, possibly due to the process of sample collection as suggested [27]. This evidence concerns the gene ALDH1A1 and triple-negative breast carcinoma.